younetwork
Kritika_Patil Criou um novo artigo
1 y

Bevacizumab Business Outlook: Analysis and Opportunities by 2025 - 2030 | #bevacizumab Market

Bevacizumab Business Outlook: Analysis and Opportunities by 2025 - 2030

Bevacizumab Business Outlook: Analysis and Opportunities by 2025 - 2030

Data Bridge Market Research analyses that the market, which was USD 6,679.14 million in 2022, would rocket up to USD 12,967.08 million by 2030 and is expected to undergo a CAGR of 9.20% during the forecast period.